Comparative Pharmacology
Head-to-head clinical analysis: ACTRON versus NAPROXEN SODIUM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTRON versus NAPROXEN SODIUM.
ACTRON vs NAPROXEN SODIUM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen (paracetamol) is a non-opioid analgesic and antipyretic. Its mechanism is not fully understood but involves inhibition of cyclooxygenase (COX) enzymes in the central nervous system, reducing prostaglandin synthesis. It also modulates the endocannabinoid system and serotonergic pathways.
Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor, reducing prostaglandin synthesis.
Oral: 400 mg every 4-6 hours as needed for pain; maximum 1200 mg/day.
220-550 mg orally twice daily; maximum 1375 mg/day.
None Documented
None Documented
Terminal elimination half-life 2-4 hours; prolonged to 6-12 hours in elderly or renal impairment (CrCl <30 mL/min).
12–17 hours (terminal); allows twice-daily dosing; prolonged in elderly and renal impairment
Renal: 90% as unchanged drug; biliary/fecal: 10% as metabolites.
Renal: 95% (as unchanged drug, conjugated naproxen, and 6-O-desmethyl naproxen); Fecal: <5%
Category C
Category D/X
NSAID
NSAID